SCHEMBL15065366

SCHEMBL15065366

COc1ccc(C=O)c(Oc2cccc(Cl)c2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.59
▸ CYP1A2 P05177 6/20 0.51
▸ LMNA P02545 4/20 0.51
▸ CYP2C19 P33261 3/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ TRIM24 O15164 1/20 0.46
▸ TYR P14679 1/20 0.46
▸ TRIM33 Q9UPN9 1/20 0.46
▸ CYP1A1 P04798 3/20 0.44
▸ CYP1B1 Q16678 3/20 0.44
▸ PGR P06401 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ EGFR P00533 1/20 0.43
▸ LCK P06239 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ ERN1 O75460 2/20 0.43
▸ SLC6A4 P31645 2/20 0.42
▸ SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23709944 0.86 SLC6A4 (0.50) CYP1A2LMNACYP2C19CYP2C9ERN1
SCHEMBL3838372 0.85 ALDH1A1 (0.67) ALDH1A1CYP1A2LMNACYP2C19CYP2C9
SCHEMBL15066478 0.82 LMNA (0.71) ALDH1A1LMNAKDM4EPOLBGAA
SCHEMBL15066479 0.82 LMNA (0.71) ALDH1A1LMNAKDM4EPOLBGAA
SCHEMBL6230766 0.81 ALDH1A1 (0.56) ALDH1A1CYP1A2LMNACYP2C19CYP2C9
SCHEMBL5319954 0.80 LMNA (0.66) ALDH1A1CYP1A2LMNACYP2C19CYP2C9
SCHEMBL25333237 0.80 TDP1 (0.56) ALDH1A1CYP1A2LMNACYP2C19CYP2C9
SCHEMBL19563634 0.80 ALDH1A1 (0.64) ALDH1A1CYP1A2LMNACYP2C19CYP2C9
SCHEMBL20346747 0.79 ALDH1A1 (0.63) ALDH1A1CYP1A2LMNACYP2C19CYP2C9
SCHEMBL25333119 0.79 ALDH1A1 (0.53) ALDH1A1CYP1A2LMNACYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US disclosed
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US disclosed
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US disclosed
EP-2797875-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 Pharmacyclics, Inc. (US) 2014-11-05 — — EP disclosed
WO-2013101600-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS, INC. (US) 2013-07-04 — — WO disclosed
WO-2013101600-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS, INC. (US) 2013-07-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 HDAC8, HDAC5, HDAC7 ALDH1A1 688/4885CYP1A2 3124/4885LMNA 537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback